Medical Imaging Market Update 2023: Predicted to Surpass USD 68.8 Billions by 2030

According to the report published by Allied Market Research, the global medical/diagnostic imaging market garnered $38.5 billion in 2020, and is expected to reach $68.8 billion by 2030, witnessing a CAGR of 5.8% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

Market Growth: The medical imaging market has been experiencing significant growth over the past decade and is expected to continue expanding. Factors such as technological advancements, increasing prevalence of chronic diseases, and rising demand for early and accurate diagnosis are driving the market growth.

Technological Advancements: Advances in medical imaging technology have revolutionized diagnostic and therapeutic processes. Modalities like computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine have witnessed significant advancements, enabling faster and more precise imaging with improved patient safety.

Rising Demand for Point-of-Care Imaging: Point-of-care imaging, which refers to portable and handheld imaging devices, is gaining popularity due to its convenience and ability to provide immediate results. These devices are particularly useful in emergency departments, remote areas, and during bedside examinations, where immediate imaging is critical for decision-making.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/1400

Market Drivers:

Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cardiovascular disorders, cancer, neurological disorders, and orthopedic conditions drives the demand for medical imaging. Imaging techniques play a crucial role in the early detection, diagnosis, and monitoring of these diseases, thereby facilitating timely treatment and improved patient outcomes.

Technological Advancements: Continuous advancements in medical imaging technology have significantly improved the quality and efficiency of diagnostic imaging. Innovations such as higher-resolution scanners, faster imaging techniques, three-dimensional (3D) and four-dimensional (4D) imaging, and hybrid imaging modalities have enhanced the accuracy, speed, and comprehensiveness of medical imaging, driving its adoption.

Market Segmentation:

By Technology/Modality:

Computed Tomography (CT) Scanners
Magnetic Resonance Imaging (MRI) Systems
X-ray Imaging Systems
Ultrasound Systems
Nuclear Imaging Systems (PET, SPECT)
Mammography Systems
Fluoroscopy Systems
Others (Endoscopy, Optical Imaging, etc.)

By Application:

Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Urology
Pulmonology
Others (Dentistry, Ophthalmology, etc.)

By End User:

Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Research and Academic Institutes
Others (Clinics, Emergency Care Centers, etc.)

By Region:

North America (United States, Canada)
Europe (United Kingdom, Germany, France, Italy, Spain, Rest of Europe)
Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
Latin America (Brazil, Mexico, Rest of Latin America)
Middle East and Africa (United Arab Emirates, Saudi Arabia, South Africa, Rest of Middle East and Africa).

Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/1400

Regional Growth Dynamics:

Growing Demand in Emerging Markets: The medical imaging market is witnessing significant growth in emerging markets, driven by improving healthcare infrastructure, rising healthcare spending, and increasing awareness about early disease detection. Countries in Asia-Pacific, Latin America, and the Middle East are expected to present lucrative opportunities for market players.

Competitive Landscape:

Leading players of the global medical/diagnostic imaging market analyzed in the research include Canon Inc. (Canon Medical Systems USA, Inc.), Esaote SpA, Carestream Health, Inc., Hitachi Ltd. (Hitachi Healthcare America Corporation), General Electric Company (GE Healthcare), Koninklijke Philips N.V., Hologic, Inc., Planmeca OY, Materialise NV, and Siemens AG.

Procure Complete Report at 20% Discount (258 Pages):

https://www.alliedmarketresearch.com/purchase-enquiry/1400

Related Reports :

Japan Oncology Drugs Market https://www.alliedmarketresearch.com/japan-oncology-drugs-market

LFIA Based Rapid Test Market https://www.alliedmarketresearch.com/lfia-based-rapid-test-market

Anti-Rheumatics Market https://www.alliedmarketresearch.com/anti-rheumatics-market

Psoriatic Arthritis Treatment Market https://www.alliedmarketresearch.com/psoriatic-arthritis-treatment-market-A05951

Contact:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free):

+1-800-792-5285, +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.